Renalytix Plc (LON:RENX – Get Free Report) traded up 6.3% during trading on Wednesday . The stock traded as high as GBX 9 ($0.12) and last traded at GBX 8.50 ($0.11). 1,137,386 shares traded hands during mid-day trading, an increase of 136% from the average session volume of 482,253 shares. The stock had previously closed at GBX 8 ($0.11).
Renalytix Price Performance
The company has a current ratio of 0.42, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95. The company has a 50 day simple moving average of GBX 11.91 and a 200 day simple moving average of GBX 18.74. The stock has a market cap of £13.27 million, a P/E ratio of -27.84 and a beta of 2.10.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Further Reading
- Five stocks we like better than Renalytix
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
